Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

Completed

• Conditions: Catheter-Related Blood Stream Infection; CLABSI - Central Line Associated Bloodstream Infection
• Interventions: Device: 70% isopropyl alcohol-impregnated catheter caps

• Registration Number: NCT04534348
• Lead Sponsor: University of Cologne

Brief Summary

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)

Detailed Description

Not available

Study Timeline

• Study Start: 2017-11-01
• Primary Completion: 2018-12-31
• Study Completion: 2020-01-31
• Study First Submitted: 2020-08-26
• Study First Submitted QC: 2020-08-26
• Study First Posted: 2020-09-01
• Status Verified: 2025-04
• Last Update Submitted: 2025-04-02
• Last Update Posted: 2025-04-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 598

Inclusion Criteria

• every patient in the hemato-oncological department who received at least one CVC was included in the study

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
CUROS	70% isopropyl alcohol-impregnated catheter caps	All central-line-associated blood stream infections (CLABSI) diagnosed during the year after the implementation of 70% isopropyl alcohol-impregnated Curos catheter caps

Primary Outcome Measures

Name	Time	Method
Number of CLABSI	12 Months	To assess the clinical efficacy of Curos in preventing CLABSI in a high-risk department (oncology and ICU)

Trial Locations

Locations (1)

University Hospital of Cologne; 🇩🇪 Cologne, Germany